Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03507231 · ClinicalTrials.gov registry record · NA
Non-integrated Costs Increase Effectiveness of Incentives
A NA study of Control - No Incentive for Flu Vaccine and Direct Incentive, sponsored by Carnegie Mellon University.
- Completed
- Registry status
- NA
- Development phase
- 12,531
- Enrollment target
- 1
- Study location
NCT03507231: Completed NA study of Control - No Incentive for Flu Vaccine and Direct Incentive, sponsored by Carnegie Mellon University.
NCT03507231 is a NA study of Control - No Incentive for Flu Vaccine and Direct Incentive that has completed, run by Carnegie Mellon University. The registered enrollment target is 12,531 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (793% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03507231, a NA study of Control - No Incentive for Flu Vaccine and Direct Incentive, has completed, sponsored by Carnegie Mellon University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,531 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will test the hypothesis that the control (no incentive) condition will have the lowest vaccination rate, the main task condition will have a significantly higher vaccination rate while the indirect condition will have the highest vaccination rate. Participants will be randomly assigned to one of the three message conditions and their vaccination records obtained from the university Occupational Health Department.
Primary Outcome
Measure the number of people who got vaccinated in the Fall 2017 semester at a large state university. We will collect vaccination records from the university Occupational Health Department
Conditions Studied
Interventions
- BEHAVIORAL Email Message
- BEHAVIORAL Incentive for Vaccination
- BEHAVIORAL Incentive for completing a short survey
Study Locations (1)
New Jersey
- Rutgers University - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,531 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2018-01-20 |
| Phase | NA |
What the finished NCT03507231 record still lists
NCT03507231 is an interventional study that assigns participants to a tested intervention. Its 12,531 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (793% higher).
The record links to 3 conditions, with Control - No Incentive for Flu Vaccine appearing as the primary indexed condition, and to 3 interventions - of which Email Message is the first listed.
NCT03507231 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03507231 about?
NCT03507231 is a clinical study titled "Non-integrated Costs Increase Effectiveness of Incentives". The investigators will test the hypothesis that the control (no incentive) condition will have the lowest vaccination rate, the main task condition will have a significantly higher vaccination rate while the indirect condition will have the highest vaccination rate. Participants will be randomly as...
What is the current status of trial NCT03507231?
This trial is currently completed. It is a NA study. The enrollment target is 12,531 participants. The study started on 2017-09-20. Estimated completion is 2018-01-20.
What conditions does trial NCT03507231 study?
This clinical trial studies the following conditions: Control - No Incentive for Flu Vaccine, Direct Incentive, Indirect Incentive.
What interventions are being tested in trial NCT03507231?
The interventions under investigation include: Email Message (BEHAVIORAL), Incentive for Vaccination (BEHAVIORAL), Incentive for completing a short survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT03507231?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03507231 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03507231's enrollment target sits among peer trials
12,531 13th of 2000 higher than 1,988 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04888832 · 12,500 participants · NA
The Effect of Work Requirements in SNAP in Virginia
- NCT05452941 · 12,500 participants
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
- NCT07069556 · 12,500 participants
ColoSense Post-Approval Study
- NCT07037433 · 12,800 participants · Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI